Wide Ranks

MLAB

Mesa Laboratories, Inc.

118.35

Top Statistics
Market Cap 642 M Forward PE 16.20 Revenue Growth 8.80 %
Current Ratio 0.70 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -107.56 % Peg Ratio Dividend Yield 0.54 %
Enterprice / EBITA 20.18 Enterprise / Revenue 3.68 Price To Sales Trailing12 Months 2.81
Profitability
Profit Margins -107.56 % Operating Margins 6.85 %
Balance Sheet
Total Cash 26 M Total Cash Per Share 4.79 Total Debt 222 M
Total Debt To Equity 138.03 Current Ratio 0.70 Book Value Per Share 29.79
All Measures
Short Ratio 332.00 % Message Board Id finmb_287550 Shares Short Prior Month 168561
Return On Equity -0.8946 City Lakewood Uuid 0bb86df1-278d-350f-8499-6d4b196d7e07
Previous Close 116.45 First Trade Date Epoch Utc 446 M Book Value 29.79
Beta 0.8650 Total Debt 222 M Volume 32401
Price To Book 3.97 Fifty Two Week Low 83.68 Total Cash Per Share 4.79
Total Revenue 228 M Shares Short Previous Month Date 1 B Target Median Price 130.00
Max Age 86400 Recommendation Mean 2.50 Sand P52 Week Change 0.3133
Operating Margins 6.85 % Last Dividend Value 0.1600 Target Mean Price 133.33
Net Income To Common -245651008 Short Percent Of Float 0.0330 Implied Shares Outstanding 5 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 44160
Average Volume10days 44160 Total Cash 26 M Next Fiscal Year End 1 B
Revenue Per Share 42.30 Held Percent Insiders 0.0575 Ebitda Margins 18.22 %
Dividend Rate 0.6400 Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 116.45 Target Low Price 120.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 120.84 Open 116.16
Dividend Yield 0.54 % State CO Free Cashflow 48 M
Return On Assets 0.0169 Time Zone Short Name EST Trailing Eps -45.62
Day Low 116.16 Address1 12100 West Sixth Avenue Trailing Annual Dividend Rate 0.6400
Price Hint 2 Shares Outstanding 5 M Target High Price 150.00
Website https://www.mesalabs.com 52 Week Change 0.3863 Average Volume 35356
Forward Eps 7.35 Recommendation Key buy Compensation As Of Epoch Date 1 B
Quick Ratio 43.20 % Is_sp_500 False Regular Market Day High 119.00
Profit Margins -107.56 % Debt To Equity 138.03 Fifty Two Week High 141.17
Day High 119.00 Shares Short 122974 Regular Market Open 116.16
Industry Key scientific-technical-instruments Earnings Growth 0.00 % Enterprise To Revenue 3.68
Revenue Growth 8.80 % Shares Percent Shares Out 0.0226 Operating Cashflow 40 M
Five Year Avg Dividend Yield 37.00 % Currency USD Market Cap 642 M
Time Zone Full Name America/New_York Is_nasdaq_100 False Zip 80228
Payout Ratio 376.47 % Quote Type EQUITY Industry Scientific & Technical Instruments
Ex Dividend Date 1 B Regular Market Day Low 116.16 Held Percent Institutions 0.9183
Long Name Mesa Laboratories, Inc. Current Price 118.35 Enterprise To Ebitda 20.18
Financial Currency USD Trailing Annual Dividend Yield 0.55 % Current Ratio 0.70
Gross Margins 63.54 % Industry Disp Scientific & Technical Instruments Number Of Analyst Opinions 3
Country United States Float Shares 5 M Two Hundred Day Average 112.11
Ir Website http://www.mesalabs.com/corporate/investor.html Enterprise Value 839 M Price To Sales Trailing12 Months 2.81
Forward PE 16.20 Regular Market Volume 32401 Last Dividend Date 1 B
Ebitda 41 M Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha 
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.

The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.

This segment also provides testing and laboratory services to the dental and pharmaceutical industries.

The Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research.

The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides.

The Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments.

This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems, offered under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands.

The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.